Objetivo "Our ITN has both scientific and therapeutic targets. Research in Work Package 1 (WP1) aims to advance understanding of normal blood cell development and why primitive cells fail to differentiate in acute myeloid leukaemia (AML). Research in WP2 will use the information gained from WP1 to develop ways of alleviating the differentiation block in AML and so deliver new agents for use in differentiation therapy. This type of therapy aims, using only mildly toxic treatments, to induce terminal maturation of leukaemia cells and accelerate their death. WP2 responds to the urgent need to devise milder treatments, especially for older and frailer AML patients. Participants have already identified a number of promising new therapeutic agents. Working across these two complementary areas will train our Early Stage Researchers (ESR) to understand the translation of new fundamental science into the development of new therapies. The ITN brings together scientists who have made important advances in the fields of haematopoiesis and differentiation therapy, so will provide an excellent scientific training in these areas. Secondments/visits by ESRs to participants who run centres of expertise in leading edge technologies will provide training in these; and the time spent with private sector participants, and the courses they provide, will ensure that ESRs acquire the transferable skills they will need if they are to work well in, and build bridges between, commercial and publicly funded research organisations. ESRs will also receive management training. This research and training, which will develop our ESRs as versatile scientists, will involve the combined efforts of prestigious research institutes and universities, Poland’s leading governmental pharmaceutical R & D institute, two successful biopharmaceutical companies and a leading management consultancy." Ámbito científico medical and health sciencesclinical medicineoncologyleukemia Programa(s) FP7-PEOPLE - Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) Tema(s) FP7-PEOPLE-2012-ITN - Marie-Curie Action: "Initial Training Networks" Convocatoria de propuestas FP7-PEOPLE-2012-ITN Consulte otros proyectos de esta convocatoria Régimen de financiación MC-ITN - Networks for Initial Training (ITN) Coordinador THE UNIVERSITY OF BIRMINGHAM Aportación de la UE € 753 274,50 Dirección Edgbaston B15 2TT Birmingham Reino Unido Ver en el mapa Región West Midlands (England) West Midlands Birmingham Tipo de actividad Higher or Secondary Education Establishments Contacto administrativo May Chung (Ms.) Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Coste total Sin datos Participantes (7) Ordenar alfabéticamente Ordenar por aportación de la UE Ampliar todo Contraer todo UNIVERSITY OF GALWAY Irlanda Aportación de la UE € 550 419,30 Dirección UNIVERSITY ROAD H91 Galway Ver en el mapa Región Ireland Northern and Western West Tipo de actividad Higher or Secondary Education Establishments Contacto administrativo Mari Vahey (Ms.) Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Coste total Sin datos UNIVERSITAT BASEL Suiza Aportación de la UE € 496 573,88 Dirección PETERSPLATZ 1 4051 Basel Ver en el mapa Región Schweiz/Suisse/Svizzera Nordwestschweiz Basel-Stadt Tipo de actividad Higher or Secondary Education Establishments Contacto administrativo Antonius Rolink (Prof.) Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Coste total Sin datos UNIWERSYTET WROCLAWSKI Polonia Aportación de la UE € 249 205,66 Dirección PL UNIWERSYTECKI 1 50137 Wroclaw Ver en el mapa Región Makroregion południowo-zachodni Dolnośląskie Miasto Wrocław Tipo de actividad Higher or Secondary Education Establishments Contacto administrativo Ewa Marcinkowska (Dr.) Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Coste total Sin datos ORBSEN THERAPEUTICS LIMITED Irlanda Aportación de la UE € 244 814,45 Dirección UNIT 1 GALWAY BUSINESS PARK H91 Galway Ver en el mapa Región Ireland Eastern and Midland Dublin Tipo de actividad Private for-profit entities (excluding Higher or Secondary Education Establishments) Contacto administrativo Stephen Elliman (Dr.) Enlaces Contactar con la organización Opens in new window Coste total Sin datos INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG Reino Unido Aportación de la UE € 285 056,62 Dirección OLD BROMPTON ROAD 123 SW7 3RP London Ver en el mapa Región London Inner London — West Kensington & Chelsea and Hammersmith & Fulham Tipo de actividad Higher or Secondary Education Establishments Contacto administrativo Yodry Vasquez (Mr.) Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Coste total Sin datos SIEC BADAWCZA LUKASIEWICZ - INSTYTUT FARMACEUTYCZNY Polonia Aportación de la UE € 448 620,90 Dirección UL. RYDYGIERA 8 01 793 Warszawa Ver en el mapa Región Makroregion województwo mazowieckie Warszawski stołeczny Miasto Warszawa Tipo de actividad Other Contacto administrativo Andrzej Kutner (Dr.) Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Coste total Sin datos CELENTYX LIMITED Reino Unido Aportación de la UE € 285 056,62 Dirección VINCENT DRIVE 97 B15 2SQ BIRMINGHAM Ver en el mapa Tipo de actividad Private for-profit entities (excluding Higher or Secondary Education Establishments) Contacto administrativo Catherine Brady (Dr.) Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Coste total Sin datos
